Lumida
/PBYI
⌘K
Puma Biotechnology Inc

Puma Biotechnology Inc

PBYI
$8.53USD+1.55%+0.13 today

MARKET CAP

434.2M

P/E (TTM)

17.5x

FWD P/E

27.3x

DAY RANGE

$8 – $9

52W RANGE

$3
$9

AI Summary

Stalk
Sell NowMedium

The asset exhibits a classic blow-off top with a long upper wick and high-volume exhaustion in Stage 2, suggesting medium-term reversal risk; short-term rejection at resistance and overbought conditions favor immediate bearish engagement through a sell now posture, targeting the recent resistance zone with rejection-based execution.

  • FY26 Nearlink revenue guidance of $202–206M, up vs prior
  • Neratinib new prescriptions increased ~25% quarter-over-quarter
  • Q1 2026 product revenue fell to $42M from $59.9M in Q4 2025
Full analysis →
Insider Trades27 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 6, 2026SellPBYIDouglas M Hunt8,460$8.26$434.2M-1.50%+181.52%$69.9K-4.12%10b5-1Sell Now
Jul 6, 2026SellPBYIMaximo F NouguesChief Financial Officer9,386$8.26$434.2M-1.50%+181.52%$77.6K-3.91%10b5-1Sell Now
Jul 6, 2026SellPBYIAlan H AuerbachPresident and CEO44,058$8.26$434.2M-1.50%+181.52%$364.1K-0.60%10b5-1Sell Now
Jan 6, 2026SellPBYIDouglas M Hunt8,987$5.86$434.2M-1.50%+181.52%$52.7K-2.76%10b5-1Sell Now
Jan 6, 2026SellPBYIMaximo F NouguesChief Financial Officer10,945$5.86$434.2M-1.50%+181.52%$64.2K-2.71%10b5-1Sell Now
Jan 6, 2026SellPBYIAlan H AuerbachPresident and CEO34,950$5.86$434.2M-1.50%+181.52%$204.9K-0.24%10b5-1Sell Now
Jul 8, 2025SellPBYIDouglas M Hunt7,817$3.53$434.2M-1.50%+181.52%$27.6K-2.29%10b5-1Sell Now
Jul 8, 2025SellPBYIMaximo F NouguesChief Financial Officer9,522$3.53$434.2M-1.50%+181.52%$33.6K-2.26%10b5-1Sell Now
Jul 8, 2025SellPBYIAlan H AuerbachPresident and CEO47,172$3.53$434.2M-1.50%+181.52%$166.7K-0.33%10b5-1Sell Now
Jan 2, 2025SellPBYIDouglas M Hunt8,633$3.15$434.2M-1.50%+181.52%$27.2K-6.48%10b5-1Sell Now
Jan 2, 2025SellPBYIJeffrey Jerome LudwigChief Commercial Officer9,437$3.15$434.2M-1.50%+181.52%$29.7K-7.97%10b5-1Sell Now
Jan 2, 2025SellPBYIMaximo F NouguesChief Financial Officer10,227$3.15$434.2M-1.50%+181.52%$32.2K-6.29%10b5-1Sell Now
Jan 2, 2025SellPBYIAlan H AuerbachPresident and CEO33,841$3.15$434.2M-1.50%+181.52%$106.7K-0.48%10b5-1Sell Now
Jul 17, 2024SellPBYIJeffrey Jerome LudwigChief Commercial Officer2,598$3.70$434.2M-1.50%+181.52%$9.6K-2.15%10b5-1Sell Now
Jul 17, 2024SellPBYIDouglas M Hunt3,637$3.70$434.2M-1.50%+181.52%$13.5K-2.66%10b5-1Sell Now
Jul 17, 2024SellPBYIMaximo F NouguesChief Financial Officer4,156$3.70$434.2M-1.50%+181.52%$15.4K-2.49%10b5-1Sell Now
Jul 17, 2024SellPBYIAlan H AuerbachPresident and CEO21,920$3.70$434.2M-1.50%+181.52%$81.1K-0.31%10b5-1Sell Now
Jul 2, 2024SellPBYIDouglas M Hunt4,349$3.27$434.2M-1.50%+181.52%$14.2K-3.08%10b5-1Sell Now
Jul 2, 2024SellPBYIMaximo F NouguesChief Financial Officer5,295$3.27$434.2M-1.50%+181.52%$17.3K-3.08%10b5-1Sell Now
Jul 2, 2024SellPBYIJeffrey Jerome LudwigChief Commercial Officer6,051$3.27$434.2M-1.50%+181.52%$19.8K-4.76%10b5-1Sell Now
Jul 2, 2024SellPBYIAlan H AuerbachPresident and CEO18,885$3.27$434.2M-1.50%+181.52%$61.7K-0.27%10b5-1Sell Now
Jan 3, 2024SellPBYIAlvin F WongChief Scientific Officer7,733$4.49$434.2M-1.50%+181.52%$34.7K-7.30%10b5-1Sell Now
Jan 3, 2024SellPBYIDouglas M Hunt8,358$4.49$434.2M-1.50%+181.52%$37.5K-7.48%10b5-1Sell Now
Jan 3, 2024SellPBYIJeffrey Jerome LudwigChief Commercial Officer12,956$4.49$434.2M-1.50%+181.52%$58.1K-11.47%10b5-1Sell Now
Jan 3, 2024SellPBYIMaximo F NouguesChief Financial Officer15,682$4.49$434.2M-1.50%+181.52%$70.3K-10.86%10b5-1Sell Now
Jan 3, 2024SellPBYIAlan H AuerbachPresident and CEO41,396$4.49$434.2M-1.50%+181.52%$185.7K-0.59%10b5-1Sell Now
Dec 4, 2023SellPBYIAlvin F WongChief Scientific Officer280$3.76$434.2M-1.50%+181.52%$1.1K-0.29%10b5-1Sell Now